Metatron 4025 Hunter and NLS study in rectal cancer
Metatron 4025 Hunter and NLS study in rectal cancer
Today, oncology is an area where 3D NLS imaging methods can also be widely used. However, until today, the application of 3D NLS studies in patients undergoing bladder tumor surgery has also included dynamic monitoring of organ status for early detection of recurrent tumors and metastases. The introduction of the 3D NLS approach into clinical practice by the Metatron 4025 Hunter could completely change the perspective on this issue. We think this question is really hot because most surgical patients have undergone traumatic transurethral resections.
The application of 3D NLS studies with spectral entropy analysis, performed during surgical incisions, allowed us to detect other tumor tumors not documented by 2D NLS studies in 37% of patients. The application of three-dimensional methods can determine the extent of local spread of the tumor process, control the depth of bladder wall resection, and reduce the risk of complications during incision.
Usually, the diagnosis and morphological verification of rectal cancer are not difficult. However, it is not always possible to assess the extent of organ wall invasion by standard diagnostic methods. Traditional two-dimensional NLS studies have been widely used as a diagnostic method for rectal recurrent cancer after organ removal. However, initial diagnosis of disease by 2D NLS imaging has been hampered for several reasons. First, it can be explained by the fact that the rectum is only partially shown (80% of the surface area of the entire organ) on a 2D NLS scan.
The application of three-dimensional NLS imaging can accurately distinguish all layers of the rectal wall, thereby diagnosing the depth of tumor invasion and determining the stage of the disease using spectral entropy analysis. This method facilitates the detection of lymph node changes larger than 1.5 mm in pararectal lymph node metastases. During monitoring of ongoing preoperative radiotherapy, 3D NLS imaging helps to accurately detect reductions in tumor size, identify changes in its structure, correlate with medical pathological morphology, and identify reductions in tumor infiltration of pararectal tissue. Therefore, 3D NLS imaging can be considered as a preliminary diagnostic method for rectal cancer. It allows the therapist to address the most important diagnostic questions related to identifying the length of the tumor process, the extent of local spread of the tumor and monitoring the efficiency of preoperative treatment performed. In organ-sparing surgery, 3D NLS imaging can be used as an effective method for the early diagnosis of recurrent tumors in the anastomotic region.
In conclusion, as a result of the short nature of modern 3D NLS imaging methods, we would like to emphasize that the Metatron 4025 Hunter's approach can effectively achieve goals such as detection of tumor changes, determination of disease stage, and qualitative assessment of therapy.